线粒体DNA
肿瘤微环境
线粒体
线粒体ROS
细胞生物学
下调和上调
癌症免疫疗法
先天免疫系统
免疫系统
免疫疗法
胞浆
活性氧
炎症
癌症研究
生物
免疫学
生物化学
基因
酶
作者
An Cheng,Li-Chun Cheng,Cheng-Liang Kuo,Yu Kang Lo,Han‐Yu Chou,Chung‐Hsing Chen,Yihao Wang,Tsung‐Hsien Chuang,Shih‐Jung Cheng,Alan Yueh‐Luen Lee
标识
DOI:10.1136/jitc-2020-001372
摘要
Background Mitochondrial Lon is a chaperone and DNA-binding protein that functions in protein quality control and stress response pathways. The level of Lon regulates mitochondrial DNA (mtDNA) metabolism and the production of mitochondrial reactive oxygen species (ROS). However, there is little information in detail on how mitochondrial Lon regulates ROS-dependent cancer immunoescape through mtDNA metabolism in the tumor microenvironment (TME). Methods We explored the understanding of the intricate interplay between mitochondria and the innate immune response in the inflammatory TME. Results We found that oxidized mtDNA is released into the cytosol when Lon is overexpressed and then it induces interferon (IFN) signaling via cGAS-STING-TBK1, which upregulates PD-L1 and IDO-1 expression to inhibit T-cell activation. Unexpectedly, upregulation of Lon also induces the secretion of extracellular vehicles (EVs), which carry mtDNA and PD-L1. Lon-induced EVs further induce the production of IFN and IL-6 from macrophages, which attenuates T-cell immunity in the TME. Conclusions The levels of mtDNA and PD-L1 in EVs in patients with oral cancer function as a potential diagnostic biomarker for anti-PD-L1 immunotherapy. Our studies provide an insight into the immunosuppression on mitochondrial stress and suggest a therapeutic synergy between anti-inflammation therapy and immunotherapy in cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI